Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FBHE4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,540
Award facts
- Contract value 100% obligated
- $4,540.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on September 4, 2025, with an ultimate completion date of September 5, 2025. The order, valued at $4,540.22 under a firm fixed price contract type, covers Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. The award involved no set-aside designation and was competitively awarded. Performance of this delivery order is based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters. This delivery order is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical supply chain. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a wide range of pharmaceutical products including diabetes medications, neurological treatments, pain management drugs, antibiotics, and specialized medical supplies. The comprehensive DLA prime IDV enables AmerisourceBergen to supply military healthcare systems and other government agencies worldwide with brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Ozempic reflects the company's ongoing role in supporting federal healthcare procurement needs.
Quick answers
Who was awarded contract SPE2DB25FBHE4?
SPE2DB25FBHE4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FBHE4 worth?
The government has obligated $4,540 on SPE2DB25FBHE4.
Is contract SPE2DB25FBHE4 an order under another contract?
Yes. SPE2DB25FBHE4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBHE4 competed?
The extent of competition for SPE2DB25FBHE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award